Private Equity

Just seven years after its founding, IEQ Capital sees four founders named to Forbes' elite list. Here's how they built a $42 billion wealth powerhouse.

San Diego's Dunham joins the nation's elite financial firms. Discover the unique 40-year strategy and performance-based fees driving their success.

AI cloud specialist CoreWeave raises another $1 billion in high-yield debt, doubling down on its aggressive expansion to meet insatiable AI demand.

The Dallas-based asset manager taps veteran Rob O’Connor to lead a new platform, capitalizing on surging investor demand for liquidity in private credit.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

A strategic partnership with 5 Horizons Ventures accelerates Marvel Biosciences' novel drug, MB-204, into human trials for autism, Rett syndrome, and more.

After a period of explosive growth under Owner Resource Group, the tech-forward BPO provider begins a new chapter with Chicago-based private equity firm Frontenac.

A new ultra-low fee for large deals challenges traditional brokers and signals a digital revolution in the multi-billion dollar secondary market.

PMGC Holdings touts major acquisitions and a promising biotech pipeline, but a look at its financials reveals a high-stakes bet on future growth.

RA Capital's major investment extends Karyopharm's runway, but future funding is now directly tied to the outcome of its pivotal endometrial cancer trial.

Goldman Sachs' strategic investment extends GeoWealth's Series C, signaling a major push to dominate the future of customized wealth management technology.

A new biotech spins out with a novel drug class aiming to provide healthier, more durable weight loss and combat cancer-related wasting syndrome.

Nearly a century old, NPF Investment Advisors launches an actively managed ETF, aiming to deliver tax efficiency and long-term growth to a new generation.

UK's Abselion opens a US base in Cambridge, MA, aiming to disrupt biologics R&D with its rapid Amperia protein quantification system.

With $336M in the bank and three autoimmune drugs advancing, Jade Biosciences lays out a fast-paced timeline for key clinical milestones in 2026 and 2027.

Industry veteran Louise Baker is named Managing Director of TricorBraun ANZ, a strategic move to unify recent acquisitions and drive growth in the region.

A new MMA league is letting fans and fighters buy in. With veteran leaders and a $5M equity raise, can the Global Fight League disrupt the octagon?

Montréal startup JetScale AI lands an oversubscribed seed round for its AI platform that slashes cloud spending and energy waste in just minutes.

Energy firm Prevalon and crypto bank Anchorage Digital add Strategy's high-yield STRC to their treasuries, marking a key step for institutional adoption.

Insurance giant Kuvare Holdings fires back at inaccurate reports, clarifying its independent oversight in a complex asset management deal with Blue Owl.